Author(s): Khan Zhaeer
Globally, the rates of fatality owing to lung cancer continue to increase each year. Nonetheless, scientists are engaged in studies to develop drugs by evaluating the patients’ reactions to chemotherapeutic treatments to choose new targets for enhanced therapies